GMED Company Financials

GMED 
$15.22
*  
0.14
  negative  
0.91%
Get GMED Alerts
*Delayed - data as of May 24, 2013 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 12/31/2012 12/31/2011 12/31/2010
Total Revenue
$385,994 $331,478 $288,195
Cost of Revenue
$75,199 $68,796 $53,825
Gross Profit
$310,795 $262,682 $234,370
Operating Expenses
Research and Development
$27,926 $23,464 $21,309
Sales, General and Admin.
$168,862 $140,386 $122,589
Non-Recurring Items
($786) $1,470 $2,787
Other Operating Items
$0 $0 $0
Operating Income
$114,793 $97,362 $87,685
Add'l income/expense items
($140) ($413) $54
Earnings Before Interest and Tax
$114,653 $96,949 $87,739
Interest Expense
$0 $0 $0
Earnings Before Tax
$114,653 $96,949 $87,739
Income Tax
$40,822 $36,165 $33,281
Minority Interest
$0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0
Net Income-Cont. Operations
$73,831 $60,784 $54,458
Net Income
$73,831 $60,784 $54,458
Net Income Applicable to Common Shareholders
$73,831 $60,784 $54,458

See also: Company Financials data entry page